These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1992862)

  • 41. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
    Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
    Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of indobufen on leukocyte-dependent thrombocyte aggregation in patients with ischemic heart disease].
    Liusov VA; Diukov IV; Uteshev DV
    Kardiologiia; 1993; 33(4):22-3. PubMed ID: 7933785
    [No Abstract]   [Full Text] [Related]  

  • 43. Clinical pharmacology studies with indobufen (K 3920): inhibitor of platelet aggregation.
    Vinazzer H; Fuccella LM
    J Clin Pharmacol; 1980; 20(5-6 Pt 1):316-25. PubMed ID: 7400367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Indobufen vs acetylsalicylic acid plus dipyridamole in long-term patency after femoropopliteal bypass.
    D'Addato M; Curti T; Bertini D; Donini I; Ferrero R; Fiorani P; Pellegrino F; Vecchioni R; Visconti W; Zinicola N
    Int Angiol; 1992; 11(2):106-12. PubMed ID: 1402213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the cyclo-oxygenase inhibitor indobufen on platelet accumulation in prosthetic vascular grafts.
    Lane IF; Irwin JT; Jennings SA; Poskitt KR; Meek AC; McCollum CN
    Br J Surg; 1986 Jul; 73(7):563-5. PubMed ID: 3730789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Effect of treatment with indobufen on blood viscosity indices and exercise tolerance in patients with coronary disease].
    Rdzanek H; Kochmański M; Zochowski RJ
    Wiad Lek; 1993 Apr; 46(7-8):245-9. PubMed ID: 8249409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prostacyclin-sparing effect of indobufen vs. aspirin.
    De Caterina R; Giannessi D; Bernini W; Lazzerini G; Lavezzari M; Stragliotto E; Biagi G; Coccheri S
    Thromb Haemost; 1996 Mar; 75(3):510-4. PubMed ID: 8701417
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Different patterns of inhibition of adrenaline-induced platelet aggregation and kinetics in vivo by acetylsalicylic acid and indobufen.
    Fortunato JS; Pinheiro MJ; Monteiro MC; Rodrigues MA; Amaral I
    J Int Med Res; 1991; 19(4):305-17. PubMed ID: 1916004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial.
    Mohler ER; Hiatt WR; Olin JW; Wade M; Jeffs R; Hirsch AT
    J Am Coll Cardiol; 2003 May; 41(10):1679-86. PubMed ID: 12767646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of policosanol (10 mg/d) versus aspirin (100 mg/d) in patients with intermittent claudication: a 10-week, randomized, comparative study.
    Illnait J; Castaño G; Alvarez E; Fernández L; Mas R; Mendoza S; Gamez R
    Angiology; 2008; 59(3):269-77. PubMed ID: 18388038
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Treatment with indobufen of platelet hyperaggregation in a group of patients with vascular diseases].
    Barbieri U; Cappelli S; Zaniol P; Righi A; Artusi P; Scorrano M
    Minerva Med; 1991; 82(1-2):63-7. PubMed ID: 2000177
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of spontaneous platelet aggregation and adhesion by indobufen (K 3920). A randomized, double-blind crossover study on platelet, coagulation and fibrinolysis function tests.
    Nenci GG; Berrettini M; Iadevaia V; Parise P; Ballatori E
    Pharmatherapeutica; 1982; 3(3):188-94. PubMed ID: 7134226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution].
    Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S
    Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518
    [No Abstract]   [Full Text] [Related]  

  • 54. Randomised controlled trial of percutaneous transluminal angioplasty for intermittent claudication.
    Whyman MR; Fowkes FG; Kerracher EM; Gillespie IN; Lee AJ; Housley E; Ruckley CV
    Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):167-72. PubMed ID: 8760978
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The incidence of deep venous thrombosis in patients with an acute myocardial infarction treated with acenocoumarol or indobufen.
    Peters SH; Jonker JJ; de Boer AC; den Ottolander GJ
    Thromb Haemost; 1982 Oct; 48(2):222-5. PubMed ID: 7179201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. PGE(1) treatment of severe intermittent claudication (short-term versus long-term, associated with exercise)--efficacy and costs in a 20-week, randomized trial.
    Belcaro G; Nicolaides AN; Agus G; Cesarone MR; Geroulakos G; Pellegrini L; De Sanctis MT; Incandela L; Ricci A; Mondani P; De Angelis R; Ippolito E; Barsotti A; Vasdekis S; Ledda A; Christopoulos D; Errichi BM; Helmis H; Cornelli U; Ramaswami G; Dugall M; Bucci M; Martines G; Ferrari PG; Corsi M; Di Francescantonio D
    Angiology; 2000 Aug; 51(8 Pt 2):S15-26. PubMed ID: 10959507
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina.
    Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A
    Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Long-term effects of indobufen on several parameters of blood platelet function in subjects at thrombotic risk].
    Di Blasi S; Pintacuda S; Ferotti N; Lo Coco L; Muratore A; Russo G; Di Blasi U; D'Alessandro M; Morici G; Fornaciari M
    G Clin Med; 1990 Dec; 71(12):727-31. PubMed ID: 2150826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cilostazol for peripheral arterial disease.
    Robless P; Mikhailidis DP; Stansby GP
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003748. PubMed ID: 18254032
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparative study between indobufen and acetylsalicylic acid on beta-thromboglobulin, platelet factor 4 and platelet aggregation in patients with transient ischemic attacks.
    Orefice G; Carrieri P; Indaco A; Iorillo L; Fioretti A
    Acta Neurol (Napoli); 1984 Apr; 6(2):97-103. PubMed ID: 6204513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.